Press "Enter" to skip to content

New patent for Daiichi Sankyo drug TURALIO

0
Copyright © DrugPatentWatch. Originally published at New patent for Daiichi Sankyo drug TURALIO

Annual Drug Patent Expirations for TURALIO
Annual Drug Patent Expirations for TURALIO

Turalio is a drug marketed by Daiichi Sankyo Inc and is included in one NDA. It is available from one supplier. There are nine patents protecting this drug.

This drug has one hundred and one patent family members in thirty-eight countries.

The generic ingredient in TURALIO is pexidartinib hydrochloride. One supplier is listed for this compound. Additional details are available on the pexidartinib hydrochloride profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for Daiichi Sankyo drug TURALIO
    Get the DrugPatentWatch Daily Briefing

    ✓ Patent Expirations and Generic Entry

    ✓ Insightful Articles & Case Studies

    ✓ Patent Litigation & Challenges

    ✓ 505(b)(2) & Biosimilars

    ✓ Industry Trends

    Do NOT follow this link or you will be banned from the site!